Alanine and Terbutaline in Treatment of Hypoglycemia in IDDM

OBJECTIVE To test the hypothesis that, in contrast to administration of glucose or glucagon, administration of the amino acid Ala or of the beta 2-adrenergic agonist terbutaline produces sustained glucose recovery from hypoglycemia. RESEARCH DESIGN AND METHODS We developed a model of clinical hyp…